Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease Patients Hospitalized With a Central Line.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
medline:
25
4
2023
pubmed:
24
2
2023
entrez:
23
2
2023
Statut:
ppublish
Résumé
Patients hospitalized with inflammatory bowel disease (IBD) have increased risk of venous thromboembolism (VTE). The aim of this study was to determine whether the adoption of a VTE protocol would change rates of medical VTE prophylaxis (low molecular weight heparin) in patients with IBD and a central venous catheter (CVC), while subsequently decreasing the incidence of VTE in this population. A protocol for VTE prophylaxis in IBD was established in March of 2018. Every patient hospitalized with an IBD flare and central venous access from March 2013 to March 2020 was identified. Study data, including patient demographics, rates of Doppler ultrasound (US), and rates of VTE were collected using International Classification of Diseases (ICD)-10 codes, CPT codes, and chart review retrospectively. Determination of an IBD flare was based on physician global assessment. Groups were compared with independent-sample t tests and chi-squared tests. A total of 313 hospitalizations across 187 different patients were identified that met criteria including IBD and central venous access. VTE prophylaxis increased from 5.24% (n = 12) prior to the intervention to 63.10% (n = 53) after the intervention [chi-square (1, N = 313) = 125.0192, P < 0.001]. Rate of Doppler US increased from 9.17% (n = 21) prior to the intervention to 17.86% (n = 15) after the intervention [chi-square (1, N = 313) = 4.5562, P < 0.05]. Diagnosis of VTE increased from 0.87% (n = 2) prior to the intervention to 7.14% (n = 6) after the intervention [chi-square (1, N = 313) = 9.6992, P < 0.01]. There were no significant differences in the demographic characteristics pre- versus post-intervention. Rates of Doppler US and VTE prophylaxis use increased significantly after implementation of a VTE protocol. Rates of VTE diagnosis also increased, though we suspect this may be due to missed diagnoses prior to implementation of the protocol and increased risk awareness after the protocol was established.
Identifiants
pubmed: 36821846
doi: 10.1097/MPG.0000000000003747
pii: 00005176-202305000-00010
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
610-615Informations de copyright
Copyright © 2023 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Papa A, Papa V, Marzo M, et al. Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. Inflamm Bowel Dis 2015;21:1204–13. doi:10.1097/MIB.0000000000000310.
doi: 10.1097/MIB.0000000000000310
Yuhara H, Steinmaus C, Corley D, et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013;37:953–62. doi:10.1111/apt.12294.
doi: 10.1111/apt.12294
Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011;60:937–43. doi:10.1136/gut.2010.228585.
doi: 10.1136/gut.2010.228585
Kuenzig ME, Consortium CG-IE, Bitton A, et al. Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study. J Crohns Colitis. 2021. doi:10.1093/ECCO-JCC/JJAB113.
doi: 10.1093/ECCO-JCC/JJAB113
Aardom MA, Klomberg RC, Kemos P, et al. The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease: a prospective international cohort study based on the PIBD-SETQuality safety registry. J Crohns Colitis 2022;16:695–707. doi:10.1093/ECCO-JCC/JJAB171.
doi: 10.1093/ECCO-JCC/JJAB171
Zitomersky NL, Levine AE, Atkinson BJ, et al. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57:343–7. doi:10.1097/MPG.0B013E31829CE5CD.
doi: 10.1097/MPG.0B013E31829CE5CD
Papa A, Gerardi V, Marzo M, et al. Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. 2014. doi:10.3748/wjg.v20.i12.3173.
Mitchel EB, Rosenbaum S, Gaeta C, et al. Venous thromboembolism in pediatric inflammatory bowel disease: a case-control study. J Pediatr Gastroenterol Nutr 2021;72:742–7. doi:10.1097/MPG.0000000000003078.
doi: 10.1097/MPG.0000000000003078
Koutroubakis IE. Therapy insight: vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005;2:266–72. doi:10.1038/ncpgasthep0190.
doi: 10.1038/ncpgasthep0190
Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr 2018;6:142. doi:10.3389/fped.2018.00142.
doi: 10.3389/fped.2018.00142
Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflammatory bowel diseases: what’s the link? Thromb J 2015;13:14. doi:10.1186/s12959-015-0044-2.
doi: 10.1186/s12959-015-0044-2
Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology 2014;146:835–848.e6. doi:10.1053/j.gastro.2014.01.042.
doi: 10.1053/j.gastro.2014.01.042
Bence CM, Traynor MD, Polites SF, et al. The incidence of venous thromboembolism in children following colorectal resection for inflammatory bowel disease: a multi-center study. J Pediatr Surg 2020;55:2387–92. doi:10.1016/j.jpedsurg.2020.02.020.
doi: 10.1016/j.jpedsurg.2020.02.020
Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of paediatric ulcerative colitis, part 2: acute severe colitis – an evidence-based consensus guideline from the European Crohn’s and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:292–310.
Olivera PA, Zuily S, Kotze PG, et al. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:857–73.
Torrente F, Meade S, Benchimol E, et al. Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel. J Crohns Colitis 2022;16:1609–16. doi:10.1093/ecco-jcc/jjac073.
doi: 10.1093/ecco-jcc/jjac073
Chien KA, Hammad HT, Gerber L, Sheth S, Sockolow R, Kucine N. Pediatric gastroenterologists’ approach to venous thromboembolism prophylaxis in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2018;66:286–8. doi:10.1097/MPG.0000000000001690.
doi: 10.1097/MPG.0000000000001690
Ananthakrishnan AN, Cagan A, Gainer VS, et al. Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014;12:1905–10. doi:10.1016/j.cgh.2014.02.034.
doi: 10.1016/j.cgh.2014.02.034
Story E, Bijelic B, Penney C, et al. Safety of venous thromboprophylaxis with low molecular weight heparin in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 2021;73:604–9. doi:10.1097/MPG.0000000000003231.
doi: 10.1097/MPG.0000000000003231
Koutroumpakis E, Tsiolakidou G, Koutroubakis I. Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost 2013;39:461–8. doi:10.1055/s-0033-1343886.
doi: 10.1055/s-0033-1343886
Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001;85:430–4. doi:10.1055/s-0037-1615600.
doi: 10.1055/s-0037-1615600
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016;41:3–14. doi:10.1007/s11239-015-1311-6
doi: 10.1007/s11239-015-1311-6
Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester venous thromboembolism study (1985 to 2009). Am J Med 2014;127:829–35.e5. doi:10.1016/j.amjmed.2014.03.041
doi: 10.1016/j.amjmed.2014.03.041
Obrien SH, Stanek JR, Witmer CM, et al. The continued rise of venous thromboembolism across US children’s hospitals. Pediatrics 2022;148:e2021054649. doi:10.1542/peds.2021-054649.
doi: 10.1542/peds.2021-054649